These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 20846273

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H, Cornillet M, Björkström NK, Sturesson C, Sparrelid E.
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [Abstract] [Full Text] [Related]

  • 3. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
    Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kimura F, Miyazaki M.
    Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
    Yamashita S, Passot G, Aloia TA, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C.
    Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.
    Cheon YK, Lee TY, Lee SM, Yoon JY, Shim CS.
    HPB (Oxford); 2012 Mar; 14(3):185-93. PubMed ID: 22321037
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM, Brock G, Buell JF.
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [Abstract] [Full Text] [Related]

  • 10. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.
    Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A, Ducerf C, Rivoire M, Bachellier P, Chiche L, Nuzzo G, Regimbeau JM.
    Ann Surg; 2011 Nov; 254(5):824-29; discussion 830. PubMed ID: 22042474
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H.
    Cancer; 2003 Jun 01; 97(11):2783-90. PubMed ID: 12767091
    [Abstract] [Full Text] [Related]

  • 13. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG, Park JK, Kim HS, Kim K, Park JK, Lee KH, Lee KT, Lee JK.
    Scand J Gastroenterol; 2019 Jun 01; 54(6):740-745. PubMed ID: 31136212
    [Abstract] [Full Text] [Related]

  • 14. Cholangiocarcinoma: a 7-year experience at a single center in Greece.
    Alexopoulou A, Soultati A, Dourakis SP, Vasilieva L, Archimandritis AJ.
    World J Gastroenterol; 2008 Oct 28; 14(40):6213-7. PubMed ID: 18985813
    [Abstract] [Full Text] [Related]

  • 15. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L, Geng ZM, Song XG, Zhao YL, Noor H, Shi L, Liu QG.
    Hepatogastroenterology; 2014 Jun 28; 61(132):927-32. PubMed ID: 26158143
    [Abstract] [Full Text] [Related]

  • 16. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.
    World J Surg; 2009 Jun 28; 33(6):1247-54. PubMed ID: 19294467
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors in patients with middle and distal bile duct cancers.
    Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ.
    World J Gastroenterol; 2014 Jun 07; 20(21):6658-65. PubMed ID: 24914391
    [Abstract] [Full Text] [Related]

  • 18. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y, Lu N, Tian W, Liu T.
    Tumori; 2014 Jun 07; 100(6):e250-6. PubMed ID: 25688507
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.
    Farhat MH, Shamseddine AI, Tawil AN, Berjawi G, Sidani C, Shamseddeen W, Barada KA.
    World J Gastroenterol; 2008 May 28; 14(20):3224-30. PubMed ID: 18506930
    [Abstract] [Full Text] [Related]

  • 20. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
    Chakedis J, Spolverato G, Beal EW, Woelfel I, Bagante F, Merath K, Sun SH, Chafitz A, Galo J, Dillhoff M, Cloyd J, Pawlik TM.
    J Gastrointest Surg; 2018 Oct 28; 22(10):1697-1708. PubMed ID: 29855867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.